Extended Data Table 1 Follow-up duration calculated as time from randomization to the date of death or the database cutoff date, whichever was earliest
From: The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

From: The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer